A 12-Week Multi-Ingredient Joint Health Supplement Alleviates Activity-Related Knee Discomfort and Improves Pain-Limited Load Tolerance in Endurance-Trained Adults: A Pilot Randomized, Double-Blind, Placebo-Controlled Trial
Nutrients · 14.11.2026 · 18 (22) · 3785
DOI: 10.3390/nu18223785 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nutrients, online erschienen am 14.11.2026. Verfasst von Wentao Gu und 10 weiteren Autor:innen. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Nankai University M-Action Joint Laboratory of Nutrition Research.
Abstract (Originalsprache)
Background
Activity-related knee discomfort is common in endurance-trained adults. Multi-ingredient supplements targeting complementary biological pathways may support knee comfort and load tolerance in this population, but controlled evidence is limited.
Methods
In this randomized, double-blind, placebo- and active-comparator-controlled pilot trial, 60 endurance-trained adults (20 per group) with activity-related knee discomfort received for 12 weeks either a multi-ingredient formula (undenatured type II collagen, curcumin phytosome, and enzymatically hydrolyzed bone powder; Group A), glucosamine hydrochloride plus chondroitin sulfate (Group B), or placebo (Group C). Assessments of functional and patient-reported outcomes were conducted at baseline, week 6, week 12, and 24 h after a post-intervention half-marathon challenge. Outcome measures covered functional pain tolerance, patient-reported pain symptoms, exploratory biomarkers of cartilage turnover, inflammation, and oxidative stress.
Results
Group-by-time interactions were significant for SLSD repetitions to pain levels 2 and 5 and for VAS (all p < 0.0001). At week 12, Group A exceeded placebo for the SLSD repetitions to pain level 5 (mean difference 30.5 repetitions; 95% CI 8.7 to 52.3; p = 0.0201), for SLSD repetitions to pain level 2 (21.4; 8.8 to 34.1; p = 0.0037), and for VAS (−1.6; −2.6 to −0.7; p = 0.0030), whereas Group B differed from placebo for SLSD pain level 2 and VAS but not for the SLSD pain level 5. No direct comparison between Groups A and B was statistically significant (all adjusted p > 0.05). After the half-marathon, only Groups B and C showed significant within-group declines in ROM relative to baseline (p = 0.0262 and p = 0.0147), whereas Group A did not (p > 0.99), although between-group ROM contrasts were not significant. Biomarker changes were exploratory, and no between-group biomarker difference reached significance.
Conclusions
In this pilot trial, 12 weeks of multi-ingredient supplementation improved pain-limited knee load tolerance and self-reported knee pain relative to placebo in endurance-trained adults. These results require confirmation in a larger trial.
Förderung
- Nankai University M-Action Joint Laboratory of Nutrition Research
Zitieren
APA
Gu, W., Niu, Z., Liu, Q., Wang, H., Yu, M., Xu, M., Ji, X., Fan, D., Wang, J., Zhao, Y., & Wang, S. (2026). A 12-Week Multi-Ingredient Joint Health Supplement Alleviates Activity-Related Knee Discomfort and Improves Pain-Limited Load Tolerance in Endurance-Trained Adults: A Pilot Randomized, Double-Blind, Placebo-Controlled Trial. Nutrients, 18(22), 3785. https://doi.org/10.3390/nu18223785
Vancouver
Gu W, Niu Z, Liu Q, Wang H, Yu M, Xu M, et al. A 12-Week Multi-Ingredient Joint Health Supplement Alleviates Activity-Related Knee Discomfort and Improves Pain-Limited Load Tolerance in Endurance-Trained Adults: A Pilot Randomized, Double-Blind, Placebo-Controlled Trial. Nutrients. 2026;18(22):3785. doi:10.3390/nu18223785
BibTeX
@article{Gu2026,
author = {Gu, Wentao and Niu, Zhenhua and Liu, Qisijing and Wang, Haitao and Yu, Miao and Xu, Meiying and Ji, Xuemeng and Fan, Dancai and Wang, Jin and Zhao, Yanrong and Wang, Shuo},
title = {A 12-Week Multi-Ingredient Joint Health Supplement Alleviates Activity-Related Knee Discomfort and Improves Pain-Limited Load Tolerance in Endurance-Trained Adults: A Pilot Randomized, Double-Blind, Placebo-Controlled Trial},
journal = {Nutrients},
year = {2026},
volume = {18},
number = {22},
pages = {3785},
doi = {10.3390/nu18223785}
}
EUVIMED